Conceptualising natural and quasi experiments in public health.

Evaluations Natural experiments Public health Public health policy Quasi experiments

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
11 02 2021
Historique:
received: 14 07 2020
accepted: 28 01 2021
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 25 6 2021
Statut: epublish

Résumé

Natural or quasi experiments are appealing for public health research because they enable the evaluation of events or interventions that are difficult or impossible to manipulate experimentally, such as many policy and health system reforms. However, there remains ambiguity in the literature about their definition and how they differ from randomized controlled experiments and from other observational designs. We conceptualise natural experiments in the context of public health evaluations and align the study design to the Target Trial Framework. A literature search was conducted, and key methodological papers were used to develop this work. Peer-reviewed papers were supplemented by grey literature. Natural experiment studies (NES) combine features of experiments and non-experiments. They differ from planned experiments, such as randomized controlled trials, in that exposure allocation is not controlled by researchers. They differ from other observational designs in that they evaluate the impact of events or process that leads to differences in exposure. As a result they are, in theory, less susceptible to bias than other observational study designs. Importantly, causal inference relies heavily on the assumption that exposure allocation can be considered 'as-if randomized'. The target trial framework provides a systematic basis for evaluating this assumption and the other design elements that underpin the causal claims that can be made from NES. NES should be considered a type of study design rather than a set of tools for analyses of non-randomized interventions. Alignment of NES to the Target Trial framework will clarify the strength of evidence underpinning claims about the effectiveness of public health interventions.

Sections du résumé

BACKGROUND
Natural or quasi experiments are appealing for public health research because they enable the evaluation of events or interventions that are difficult or impossible to manipulate experimentally, such as many policy and health system reforms. However, there remains ambiguity in the literature about their definition and how they differ from randomized controlled experiments and from other observational designs. We conceptualise natural experiments in the context of public health evaluations and align the study design to the Target Trial Framework.
METHODS
A literature search was conducted, and key methodological papers were used to develop this work. Peer-reviewed papers were supplemented by grey literature.
RESULTS
Natural experiment studies (NES) combine features of experiments and non-experiments. They differ from planned experiments, such as randomized controlled trials, in that exposure allocation is not controlled by researchers. They differ from other observational designs in that they evaluate the impact of events or process that leads to differences in exposure. As a result they are, in theory, less susceptible to bias than other observational study designs. Importantly, causal inference relies heavily on the assumption that exposure allocation can be considered 'as-if randomized'. The target trial framework provides a systematic basis for evaluating this assumption and the other design elements that underpin the causal claims that can be made from NES.
CONCLUSIONS
NES should be considered a type of study design rather than a set of tools for analyses of non-randomized interventions. Alignment of NES to the Target Trial framework will clarify the strength of evidence underpinning claims about the effectiveness of public health interventions.

Identifiants

pubmed: 33573595
doi: 10.1186/s12874-021-01224-x
pii: 10.1186/s12874-021-01224-x
pmc: PMC7879679
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Subventions

Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SCAF/15/02
Pays : United Kingdom
Organisme : School for Public Health Research
ID : SPHR-PROG-PCA-WP3
Organisme : Medical Research Council
ID : MC_UU_12017/13
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU13
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU17
Pays : United Kingdom

Références

Health Econ. 2017 May;26(5):639-655
pubmed: 27046821
JAMA Psychiatry. 2014 Sep;71(9):1025-31
pubmed: 25028897
Am J Epidemiol. 2016 Apr 15;183(8):758-64
pubmed: 26994063
Int J Behav Nutr Phys Act. 2019 Nov 4;16(1):99
pubmed: 31684961
Am J Public Health. 2018 May;108(5):616-619
pubmed: 29565659
BMC Public Health. 2018 Apr 19;18(1):522
pubmed: 29673337
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Epidemiol Perspect Innov. 2012 Apr 03;9:3
pubmed: 22472125
J Clin Epidemiol. 2017 Sep;89:1-3
pubmed: 29110785
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
J Clin Epidemiol. 2019 Jul;111:105-114
pubmed: 29432858
SSM Popul Health. 2019 Dec 09;10:100526
pubmed: 31890846
J Epidemiol Community Health. 2020 Feb;74(2):203-208
pubmed: 31744848
J Epidemiol Community Health. 2012 Dec;66(12):1182-6
pubmed: 22577181
Annu Rev Public Health. 2017 Mar 20;38:39-56
pubmed: 28125392
Int J Epidemiol. 2021 Jan 23;49(6):1972-1995
pubmed: 31993631
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
J Clin Epidemiol. 2017 Sep;89:43-52
pubmed: 28351693
J Clin Epidemiol. 2017 Sep;89:30-42
pubmed: 28351692
Int J Public Health. 2019 May;64(4):637-642
pubmed: 30607473
Int J Epidemiol. 2007 Dec;36(6):1196-204
pubmed: 17591638
J Med Ethics. 2015 Oct;41(10):848-53
pubmed: 26187285
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Int J Epidemiol. 2018 Feb 1;47(1):332-347
pubmed: 29106568
J Clin Epidemiol. 2017 Sep;89:21-29
pubmed: 28365303
Annu Rev Nutr. 2019 Aug 21;39:317-338
pubmed: 31116649
BMJ. 2013 Apr 09;346:f1515
pubmed: 23571838
J Clin Epidemiol. 2017 Sep;89:4-11
pubmed: 28694121
BMJ. 2018 May 16;361:k1079
pubmed: 29769210
J Clin Epidemiol. 2017 Sep;89:53-66
pubmed: 28365306

Auteurs

Frank de Vocht (F)

Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. frank.devocht@bristol.ac.uk.
NIHR School for Public Health Research, Newcastle, UK. frank.devocht@bristol.ac.uk.
NIHR Applied Research Collaboration West, Bristol, UK. frank.devocht@bristol.ac.uk.

Srinivasa Vittal Katikireddi (SV)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Bristol, UK.

Cheryl McQuire (C)

Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
NIHR School for Public Health Research, Newcastle, UK.

Kate Tilling (K)

Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
MRC IEU, University of Bristol, Bristol, UK.

Matthew Hickman (M)

Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.

Peter Craig (P)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH